|
ZDHHC23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77190040417941E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.54990000225774E-08 |
| Normal-vs-Stage2 |
9.279000E-03 |
| Normal-vs-Stage3 |
2.165800E-01 |
| Normal-vs-Stage4 |
8.610400E-01 |
| Stage1-vs-Stage2 |
9.173000E-01 |
| Stage1-vs-Stage3 |
1.185810E-01 |
| Stage1-vs-Stage4 |
7.099700E-02 |
| Stage2-vs-Stage3 |
3.005000E-01 |
| Stage2-vs-Stage4 |
7.942300E-02 |
| Stage3-vs-Stage4 |
3.927400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.49450000153095E-08 |
| Normal-vs-AfricanAmerican |
5.85659999999821E-05 |
| Normal-vs-Asian |
3.273800E-01 |
| Caucasian-vs-AfricanAmerican |
7.714800E-01 |
| Caucasian-vs-Asian |
8.050800E-01 |
| AfricanAmerican-vs-Asian |
8.802600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29720001407208E-09 |
| Normal-vs-Female |
2.045500E-04 |
| Male-vs-Female |
9.437800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.729600E-02 |
| Normal-vs-Extreme_Weight |
1.122890E-03 |
| Normal-vs-Obese |
4.010100E-04 |
| Normal-vs-Extreme_Obese |
1.037650E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.255000E-01 |
| Normal_Weight-vs-Obese |
1.164430E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.921870E-02 |
| Extreme_Weight-vs-Obese |
5.095200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.032000E-01 |
| Obese-vs-Extreme_Obese |
3.757000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.509700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.49050000411933E-08 |
| Normal-vs-Age(61-80Yrs) |
1.93179999996573E-07 |
| Normal-vs-Age(81-100Yrs) |
5.338400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.864000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.956600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.037900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.861400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.93380000000199E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.174330E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.59134944005746E-12 |
| Normal-VS-Type2 PRCC |
1.685760E-02 |
| Normal-VS-KIRP CIMP |
3.771800E-01 |
| Normal-VS-Unclassified PRCC |
5.236600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.446300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.02470000002053E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
9.208400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.614040E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.528200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.823100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.221800E-02 |
| Normal-vs-N1 |
2.894200E-01 |
| Normal-vs-N2 |
4.100200E-01 |
| N0-vs-N1 |
6.701600E-01 |
| N0-vs-N2 |
4.039600E-01 |
| N1-vs-N2 |
4.414000E-01 |
|
|
